
    
      This project is a single-center, open clinical observation the safety and efficacy that stage
      IV limited peritoneal metastasis of gastric cancer patients accept S-1 plus hyperthermic
      intraperitoneal chemotherapy . With advanced gastric patients of confined to the peritoneal
      after CRS as the research object, with progression-free survival and overall survival,
      adverse events as the end points.
    
  